Bellerophon Therapeutics Inc buy marge
Start price
12.04.17
/
50%
€16.37
Target price
23.01.20
€67.65
Performance (%)
-68.11%
End price
23.01.20
€5.22
Summary
This prediction ended on 23.01.20 with a price of €5.22. The BUY prediction by marge for Bellerophon Therapeutics Inc performed very badly with a performance of -68.11%. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellerophon Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by marge for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 12.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 5$ zu.
Überschrift: Bellerophon, erfolgreich tätig im Markt der Pulmonary Arterial Hypertension
Buy beendet
Buy beendet